Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours - mechanisms of action

By Szepeshazi K.   Schally A.V.   Groot K.   Armatis P.   Hebert F.   Halmos G.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 128-136

Elsevier

Access to resources Recommend Favorite

Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects

By Doga M.   Bonadonna S.   Burattin A.   Giustina A.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

By Chatzistamou Ioulia   Schally Andrew   Varga Jozsef   Groot Kate   Armatis Patricia   Bajo Ana  

Journal of Cancer Research and Clinical Oncology, Vol. 127, Iss. 11, 2001-11 ,pp. : 645-652

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro

By Jaszberenyi Miklos   Schally Andrew   Block Norman   Zarandi Marta   Cai Ren-Zhi   Vidaurre Irving   Szalontay Luca   Jayakumar Arumugam   Rick Ferenc  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 281-290

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists

By Limonta P.   Pratesi G.   Moretti R.M.   Montagnani Marelli M.   Motta M.   Dondi D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1134-1135

Elsevier

Access to resources Recommend Favorite